Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Vaccines for Alzheimer’s: exploiting similarities with Down syndrome

One approach to overcome continuing challenges facing drug research and development for Alzheimer’s is a vaccine. Swiss AC Immune has developed an Abeta-focused vaccine called ACI-24, which has been both effective and safe in pre-clinical models. As well as studying ACI-24 in Alzheimer’s patients, the company is investigating the candidate in Down syndrome patients who have a genetic predisposition to developing Alzheimer’s and are a more homogenous patient group.


Go Top